1901 W. 47TH PLACE, KANSAS CITY, KS
Board Restructuring - Jeff Ervin and Jay Roberts Not Seeking Re-Election
Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for Lead ADHD Asset CTx-1301
Zhanpeng Jiang Appointed to Board of Directors of Cingulate Inc.
Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Material disclosure
Cingulate Inc. Enters $12 Million Private Placement Agreement
Cingulate Inc. Increases Offering Price to $31.9 Million Under Sales Agreement
Unregistered Sales of Equity Securities
Q1
FY 2025
Q3
Q2
Notice of Late Filing for Quarterly Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
PRE 14A
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Correspondence
Submission Upload